Variant analysis of SARS-CoV-2 strains in Middle Eastern countries
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
Background
SARS-CoV-2 is diverging from the initial Wuhan serotype, and different variants of the virus are reported. Mapping the variant strains and studying their pattern of evolution will provide better insights into the pandemic spread
Methods
Data on different SARS-CoV2 for WHO EMRO countries were obtained from the Chinese National Genomics Data Center (NGDC), Genbank and the Global Initiative on Sharing All Influenza Data (GISAID). Multiple sequence alignments (MSA) was performed to study the evolutionary relationship between the genomes. Variant calling, genome and variant alignment were performed to track the strains in each country. Evolutionary and phylogenetic analysis is used to explore the evolutionary hypothesis.
Findings
Of the total 50 samples, 4 samples did not contain any variants. Variant calling identified 379 variants. Earliest strains are found in Iranian samples. Variant alignment indicates Iran samples have a low variant frequency. Saudi Arabia has formed an outgroup. Saudi Arabia, Qatar and Kuwait were the most evolved genomes and are the countries with the highest number of cases per million.
Interpretation
Iran was exposed to the virus earlier than other countries in the Eastern Mediterranean Region.
Funding
None
Article activity feed
-
SciScore for 10.1101/2020.06.18.156810: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Sample filing: We performed multiple sequence alignments (MSA) using EMBOSS Clustal Omega8 and observed for conserved and consensus sequences to study the evolutionary relationship between the genomes. EMBOSSsuggested: (EMBOSS, RRID:SCR_008493)SNPeff, a genetic variant annotation program in the Galaxy server, was used to identify the protein level changes caused by SNPs11. SNPeffsuggested: (SnpEff, RRID:SCR_005191)Galaxysuggested: (Galaxy, RRID:SCR_006281)The genome database for … SciScore for 10.1101/2020.06.18.156810: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Sample filing: We performed multiple sequence alignments (MSA) using EMBOSS Clustal Omega8 and observed for conserved and consensus sequences to study the evolutionary relationship between the genomes. EMBOSSsuggested: (EMBOSS, RRID:SCR_008493)SNPeff, a genetic variant annotation program in the Galaxy server, was used to identify the protein level changes caused by SNPs11. SNPeffsuggested: (SnpEff, RRID:SCR_005191)Galaxysuggested: (Galaxy, RRID:SCR_006281)The genome database for both SARS-CoV-2 NC_045512.2 and SARS NC_004718 were built and compared using SNPeff, and Genbank7. SARS-CoV-2suggested: (Active Motif Cat# 91351, RRID:AB_2847848)(BEAST) v1.10.4, is used to perform Bayesian analysis of molecular sequences using MCMC14. BEASTsuggested: (BEAST, RRID:SCR_010228)The unrooted tree obtained from the models and the phylogenetic tree generated by Clustal Omega is used to predict the associations between samples. Clustal Omegasuggested: (Clustal Omega, RRID:SCR_001591)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
